When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
Fate Therapeutics (FATE) announced that after his 12-years tenure Daniel D. Shoemaker, Ph.D., Chief Scientific Officer, has advised the company that he is retiring as of June 30, 2021.Bob Valamehr, Ph.D., Chief Research and Development Officer and scientific leader of the company's iPSC Product Platform since January 2010, will continue to lead all R&D activities.Shares trading 6.4% higher premarket